Ocular Therapeutix Inc (OCUL)
4.64
-0.36
(-7.20%)
USD |
NASDAQ |
Apr 24, 16:00
4.64
0.00 (0.00%)
After-Hours: 20:00
Ocular Therapeutix Debt to Equity Ratio: 0.8222 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.8222 |
| September 30, 2023 | 9.409 |
| June 30, 2023 | 17.94 |
| March 31, 2023 | 5.631 |
| December 31, 2022 | 1.526 |
| September 30, 2022 | 1.154 |
| June 30, 2022 | 0.8008 |
| March 31, 2022 | 0.6524 |
| December 31, 2021 | 0.5845 |
| September 30, 2021 | 0.5819 |
| June 30, 2021 | 0.6261 |
| March 31, 2021 | 0.5757 |
| December 31, 2020 | 0.6509 |
| September 30, 2020 | -11.87 |
| June 30, 2020 | 9.631 |
| March 31, 2020 | -4.725 |
| December 31, 2019 | -13.58 |
| September 30, 2019 | 4.256 |
| June 30, 2019 | 5.909 |
| March 31, 2019 | 1.866 |
| Date | Value |
|---|---|
| December 31, 2018 | 0.691 |
| September 30, 2018 | 0.3112 |
| June 30, 2018 | 0.3418 |
| March 31, 2018 | 0.3474 |
| December 31, 2017 | 0.689 |
| September 30, 2017 | 0.4988 |
| June 30, 2017 | 0.371 |
| March 31, 2017 | 0.2773 |
| December 31, 2016 | 0.3008 |
| September 30, 2016 | 0.2496 |
| June 30, 2016 | 0.2194 |
| March 31, 2016 | 0.1917 |
| December 31, 2015 | 0.1705 |
| September 30, 2015 | 0.1531 |
| June 30, 2015 | 0.1379 |
| March 31, 2015 | 0.2872 |
| December 31, 2014 | 0.2533 |
| September 30, 2014 | 0.2252 |
| June 30, 2014 | -0.2114 |
| March 31, 2014 | 0.1797 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-13.58
Minimum
Dec 2019
17.94
Maximum
Jun 2023
1.609
Average
0.8008
Median
Jun 2022
Debt to Equity Ratio Benchmarks
| Assertio Holdings Inc | 0.2768 |
| CytomX Therapeutics Inc | 0.00 |
| EyePoint Pharmaceuticals Inc | 0.00 |
| Regeneron Pharmaceuticals Inc | 0.0763 |
| Cormedix Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 252.06M |
| Total Liabilities (Quarterly) | 160.93M |
| Shareholders Equity (Quarterly) | 91.13M |
| Current Ratio | 6.655 |
| Net Debt Paydown Yield | -0.84% |